These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 6213647)

  • 21. T cell reactivity to acetylcholine receptor in rats orally tolerized against experimental autoimmune myasthenia gravis.
    Wang ZY; Qiao J; Melms A; Link H
    Cell Immunol; 1993 Dec; 152(2):394-404. PubMed ID: 8258147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double seropositive myasthenia gravis with acetylcholine receptor and lipoprotein receptor-related protein 4 antibodies.
    Tsivgoulis G; Dervenoulas G; Tzartos SJ; Zompola C; Papageorgiou SG; Voumvourakis K
    Muscle Nerve; 2014 Jun; 49(6):930-1. PubMed ID: 24638957
    [No Abstract]   [Full Text] [Related]  

  • 23. [Conceptual aspects of myasthenia gravis].
    Ledro Molina D; Avilés Mejías S; Garrido Peralta M
    Rev Clin Esp; 1981 Oct; 163(1):13-6. PubMed ID: 6276939
    [No Abstract]   [Full Text] [Related]  

  • 24. Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis.
    Noguchi SA; Drachman DB; Adams RN; Hirsch RL
    Ann Neurol; 1980 Jul; 8(1):32-7. PubMed ID: 7406445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Myasthenia gravis: pathogenesis elucidated. Aetiology and relationship with thymus still unknown (author's transl)].
    de Crousaz G
    Schweiz Rundsch Med Prax; 1977 Jan; 66(4):103-6. PubMed ID: 299944
    [No Abstract]   [Full Text] [Related]  

  • 26. Accessibility to antibodies of acetylcholine receptors in the neuromuscular junction.
    Zurn AD; Fulpius BW
    Clin Exp Immunol; 1976 Apr; 24(1):9-17. PubMed ID: 949876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unravelling the pathogenesis of myasthenia gravis.
    Vincent A
    Nat Rev Immunol; 2002 Oct; 2(10):797-804. PubMed ID: 12360217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenesis and treatment of myasthenia gravis.
    Scadding GK; Havard CW
    Br Med J (Clin Res Ed); 1981 Oct; 283(6298):1008-12. PubMed ID: 6794741
    [No Abstract]   [Full Text] [Related]  

  • 29. Cholinergic neuromuscular hyperactivity in patients with myasthenia gravis seropositive for MuSK antibody.
    Punga AR; Flink R; Askmark H; Stålberg EV
    Muscle Nerve; 2006 Jul; 34(1):111-5. PubMed ID: 16453324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Humoral immunity in myasthenia gravis: immunoglobulin class, affinity, and antigenic site.
    Tindall RS
    Trans Am Neurol Assoc; 1979; 104():16-8. PubMed ID: 553397
    [No Abstract]   [Full Text] [Related]  

  • 31. Production of anti-acetylcholine receptor-alpha antibody in vitro by peripheral blood lymphocytes of patients with myasthenia gravis: role of immunoregulatory T cells and monocytes.
    Ofosu-Appiah W; Mokhtarian F; Shirazian D; Grob D
    J Lab Clin Med; 1994 Aug; 124(2):231-41. PubMed ID: 8051487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Myasthenia gravis].
    Suzumura A
    Ryoikibetsu Shokogun Shirizu; 2000; (31):20-3. PubMed ID: 11269057
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pathogenesis and pathophysiology of myasthenia gravis--role of anti-acetylcholine receptor antibody (author's transl)].
    Nishitani H; Noguchi S; Ohta K; Matsubara S
    No To Shinkei; 1980 Sep; 32(9):879-90. PubMed ID: 7437163
    [No Abstract]   [Full Text] [Related]  

  • 34. Enzyme-linked immunosorbent assay for antibody against the nicotinic acetylcholine receptor in human myasthenia gravis.
    Kawanami S; Tsuji R; Oda K
    Ann Neurol; 1984 Feb; 15(2):195-200. PubMed ID: 6367620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody to acetylcholine receptors in human MG.
    Lindstrom J
    Int J Neurol; 1980; 14(1):17-24. PubMed ID: 6293988
    [No Abstract]   [Full Text] [Related]  

  • 37. Assessment of cellular and humoral immunity of myasthenics.
    Huang SW; Rose JW; Mayer RF
    J Neurol Neurosurg Psychiatry; 1977 Nov; 40(11):1053-9. PubMed ID: 304474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell types required for anti-acetylcholine receptor antibody synthesis by cultured thymocytes and blood lymphocytes in myasthenia gravis.
    Willcox HN; Newsom-Davis J; Calder LR
    Clin Exp Immunol; 1984 Oct; 58(1):97-106. PubMed ID: 6236921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B and T cell involvement in anti-acetylcholine receptor antibody formation in myasthenia gravis.
    Shinomiya N; Yata J
    Clin Exp Immunol; 1981 Nov; 46(2):277-85. PubMed ID: 6978218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Receptors in immunology.
    Gmelig Meyling FH
    Neth J Med; 1985; 28(2):63-8. PubMed ID: 3919325
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.